Back to Search
THOMAS MOODY, M.D.
M.D.
Ophthalmology Physician
NPI: 1003815705Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
PMID 19628293·Lung Cancer·2010
7-preclinical
Common and dissociable prefrontal loci associated with component mechanisms of analogical reasoning.
PMID 19549622·Cereb Cortex·2010
8-other
Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
PMID 19463875·Peptides·2009
7-preclinical
Your brain on Google: patterns of cerebral activation during internet searching.
PMID 19155745·Am J Geriatr Psychiatry·2009
8-other
Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.
PMID 19276279·Clin Cancer Res·2009
8-other
Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states.
PMID 18185064·Curr Opin Endocrinol Diabetes Obes·2008
6-review
Bombesin marine toxin conjugates inhibit the growth of lung cancer cells.
PMID 18336841·Life Sci·2008
7-preclinical
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.
PMID 17580098·Peptides·2007
7-preclinical
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.
PMID 17351657·Br J Pharmacol·2007
7-preclinical
Vasoactive intestinal peptide receptors: a molecular target in breast and lung cancer.
PMID 17430173·Curr Pharm Des·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2055 E SOUTHERN AVE, SUITE A
TEMPE, AZ 85282 - Phone
- (480) 491-7676
Quick Facts
- NPI
- 1003815705
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile